Why Investors Shouldn’t Worry About Life360 Director Charles Prober Selling 7,930 Shares for $420,700

0 Comments

Key Points 7,930 shares were sold at $53.05 per share for a total value of ~$420,700 on July 13, 2026. The disposition reduced the insider’s direct equity position by 7%. The transaction involved the immediate open-market sale of shares acquired through the exercise of 7,930 stock options at $11.18. The sale was executed under a […]

ICICI Bank Limited (IBN) Q1 2027 Earnings Call Transcript

0 Comments

Operator Ladies and gentlemen, good day, and welcome to ICICI Bank Limited Q1 FY ’27 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I now hand the conference over to Mr. Sandeep Bakhshi, Managing Director and Chief Executive Officer of ICICI Bank. Thank you, and over to you, sir. Sandeep […]

DeFi users are missing out on $150 million a year. Here’s why

0 Comments

Around 54% of liquidity in positions below $1,000 was out of range, compared with 26% for positions above $1 million. Yet positions worth more than $1 million accounted for 47% of all idle capital, or roughly $260 million. While contract-managed positions stayed within a more consistent range, individual wallets accounted for between 82% and 94% […]

French Gambling Authority Blocks Polymarket Access

0 Comments

France’s Autorité nationale des jeux (ANJ), or the National Gambling Authority, has ordered internet service providers to block access to Polymarket. Prediction websites are considered illegal gambling, the ANJ said in a Friday press release. The regulator said that Polymarket’s operations are not authorized in France and that advertising unauthorized gambling sites constitutes a criminal […]

Surprise as ‘resilient’ UK economy grows by 0.1% in May

0 Comments

Experts have reacted with surprise after the ‘resilient’ UK economy defied expectations with 0.1% growth in May. However, they have warned that it is unlikely to be enough to pave the way for interest rates to be cut. May’s growth was a welcome boost following a 0.1% decline in April. Lindsay James, investment strategist at […]

Plug Power Wins a 50-Megawatt Order in Australia. Here’s What It Means for the Hydrogen Stock.

0 Comments

Key Points Earlier this month, Plug Power (NASDAQ: PLUG) investors received some great news: The company’s 50-megawatt (MW) hydrogen electrolyzer project in Australia is expected to move into the execution phase. This essentially clears the way for Plug Power to deliver on its end of the bargain and book the related revenue. While Plug Power […]

Tokenization has become a strategic priority for 84% of financial firms

0 Comments

On Wednesday, DTCC completed its first live production trades involving tokenized securities, marking a major step toward bringing blockchain technology into traditional financial markets. Broadridge’s findings suggest those efforts are influencing the broader industry. Sixty-eight percent of respondents said tokenization will at least partially reshape financial markets within the next three to five years, while […]

The 6-Point Checklist Every Founder Needs Before Raising Their First Dollar

0 Comments

Opinions expressed by Entrepreneur contributors are their own. Key Takeaways Investors aren’t evaluating how polished your pitch is — they’re testing whether your business can survive the structural realities of taking their money. From cap tables to burn rate to governance, the founders who close rounds are the ones who’ve pressure-tested the fundamentals long before […]

$2.5 billion in BTC call spreads target $72,000 by the month end when the Fed meets

0 Comments

“This week we have seen some large blocks in BTC topside call spreads,” Jean-David Péquignot, chief commercial officer at Deribit, told CoinDesk. Options flow of this size and repetition often reflects institutional positioning rather than retail activity, given the capital required and the precision of the strike selection. The timing is notable for two reasons. […]

Cathie Wood Just Bet Big on This Biotech Stock

0 Comments

Key Points The biotech has a strong pipeline and is growing its revenue. In June, the FDA approved Ionis’s drug, Tryngolza, to treat severe hypertriglyceridemia. The new approval expands the drug’s target market to more than 3 million patients in the U.S. alone. 10 stocks we like better than Ionis Pharmaceuticals › Cathie Wood’s ARK […]